greeksoup/ stock research

Johnson & Johnson (JNJ) FY2024 results: revenue $88.8 billion, up 4.3% on the year

Johnson & Johnson (JNJ) reported revenue of $88.8 billion for fiscal 2024, the year ended 29 December 2024, up 4.3% on the year before. Net income was $14.1 billion, down 60.0%, and diluted earnings per share $5.79. The figures are the company's own, from the 10-K it filed with the SEC on 13 February 2025.

Revenue
$88.8 billion
+4.3% on the year
FY2017FY2024
Operating margin
n/a
FY2017FY2024
Net income
$14.1 billion
-60.0% on the year
FY2017FY2024
Diluted EPS
$5.79
-57.8% on the year
FY2017FY2024

this yearthe year beforeHover a bar for its figure.

The year in brief

The four quarters: Q1 FY2024 · Q2 FY2024 · Q3 FY2024 · Q4 FY2024

Income statement (profit and loss)

$ millionFY2024FY2023FY2022On the yearLast 8 years
Revenue88,82185,15979,990+4.3%
Cost of revenue27,47126,55324,596+3.5%
Gross profit61,35058,60655,394+4.7%
Gross margin69.1%68.8%69.3%
Research and development1,8414830.0+281.2%
Selling, general and administrative22,86921,51220,246+6.3%
Interest expense755772276-2.2%
Pre-tax income16,68715,06219,359+10.8%
Income tax2,6211,7362,989+51.0%
Effective tax rate15.7%11.5%15.4%
Net income14,06635,15317,941-60.0%
Net margin15.8%41.3%22.4%
Diluted EPS$5.79$13.72$6.73-57.8%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2024FY2023FY2022On the yearLast 8 years
Operating cash flow24,26622,79121,194+6.5%
Capital expenditure4,4244,5434,009-2.6%
Free cash flow19,84218,24817,185+8.7%
Free cash flow margin22.3%21.4%21.5%
Cash from investing-18,599878-12,371
Cash from financing-3,132-15,825-8,871
Depreciation and amortisation7,3397,4866,970-2.0%
Share-based compensation1,1761,1621,138+1.2%
Buybacks2,4325,0546,035-51.9%
Dividends paid11,82311,77011,682+0.5%
Dividend per share$4.91$4.70$4.45+4.5%
Diluted shares, weighted2,429m2,560m2,664m-5.1%

Balance sheet

$ millionFY2024FY2023FY2022On the yearLast 8 years
Shareholders' equity71,49068,77476,804+3.9%
Non-controlling interestn/an/a0.0
Debt36,63429,33239,642+24.9%
Other liabilities71,98069,45270,932+3.6%
Total liabilities and equity180,104167,558187,378+7.5%
Fixed assets20,51819,89817,982+3.1%
Goodwill44,20036,55836,047+20.9%
Intangible assets37,61834,17538,489+10.1%
Investments4171,0689,392-61.0%
Cash and equivalents24,10521,85912,889+10.3%
Receivables14,84214,87314,039-0.2%
Inventory12,44411,18110,268+11.3%
Other assets25,96027,94648,272-7.1%
Total assets180,104167,558187,378+7.5%

10-K for the year ended 29 December 2024, filed 13 February 2025: the filing.